Clofion
Clopidogrel bisulfate
Indication : Clofion is indicated for the prevention of atherothrombotic events in :
1. Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
2. Patients suffering from acute coronary syndrome :
• Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction). In combination with Acetylsalicylic acid (ASA).
• ST segment elevation acute myocardial infarction. In combination with ASA in medically treated patients eligible for thrombolytic therapy.
Composition : Each Clofion Film coated tablet 75 mg contains Clopidogrel bisulfate equivalent to Clopidogrel 75 mg.
Presentation : Clofion Film coated tablet 75 mg
Box, 3 strips @ 10 film coated tablets
On medical prescription only
Store below 30°C
Other Related Products
Related products
-
Rosfion
Cardiovascular & Hematopoietic Systems -
Nicarfion®
Cardiovascular & Hematopoietic Systems -
Intorvas
Cardiovascular & Hematopoietic Systems -
Glaritus®
Cardiovascular & Hematopoietic Systems